Van Bockstaele E J, Colago E E
Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021, USA.
J Comp Neurol. 1996 Jun 10;369(4):483-96. doi: 10.1002/(SICI)1096-9861(19960610)369:4<483::AID-CNE1>3.0.CO;2-0.
The regional and cellular distribution of the different classes of excitatory amino acid receptors with respect to the noradrenergic neurons of the nucleus locus coeruleus (LC) are unknown. We therefore combined immunoperoxidase labeling for the R1 subunit of the N-methy-D-aspartate (NMDA) receptor with immunogold-silver localization of the catecholamine synthesizing enzyme, tyrosine hydroxylase (TH), in single sections through the rat LC to determine the subcellular localization of this glutamate receptor subtype with respect to the noradrenergic neurons. At the light microscopic level, there was light to moderate labeling for the NMDA-R1-like (li) receptor in the caudal pole of the LC and dense labeling in the dorsolateral aspect of the LC adjacent to the superior cerebellar peduncle. In the rostral pole of the LC which is enriched with noradrenergic dendrites, significant overlap between both immunoreactivities could be observed. At the ultrastructural level, immunoperoxidase labeling for NMDA-R1 was selectively distributed in astrocytic processes and within presynaptic axon terminals but was rarely seen in catecholamine-containing somata or dendrites. Peroxidase labeling for NMDA-R1, however, was occasionally observed in dendrites in the rostral pole of the LC. Most of these dendrites lacked detectable levels of TH, although TH immunoreactivity was apparent in the neuropil. Dendrites containing NMDA-R1-li immunoreactivity often received asymmetric (excitatory-type) contacts from unlabeled terminals. NMDA-R1-li-immunoreactive axon terminals usually contained small clear, as well as large dense-core vesicles and were often apposed to unlabeled dendrites, axon terminals and/or glial processes. These results provide the first ultrastructural evidence that NMDA-R1-li immunoreactivity is selectively distributed within astrocytic processes and presynaptic axon terminals within the LC.
不同类型兴奋性氨基酸受体相对于蓝斑核(LC)去甲肾上腺素能神经元的区域和细胞分布尚不清楚。因此,我们将N-甲基-D-天冬氨酸(NMDA)受体R1亚基的免疫过氧化物酶标记与儿茶酚胺合成酶酪氨酸羟化酶(TH)的免疫金银定位相结合,在穿过大鼠LC的单切片中,以确定该谷氨酸受体亚型相对于去甲肾上腺素能神经元的亚细胞定位。在光学显微镜水平,LC尾极有轻度至中度的NMDA-R1样(li)受体标记,在与小脑上脚相邻的LC背外侧有密集标记。在富含去甲肾上腺素能树突的LC头极,可观察到两种免疫反应性之间有明显重叠。在超微结构水平,NMDA-R1的免疫过氧化物酶标记选择性地分布在星形胶质细胞突起和突触前轴突终末内,但在含儿茶酚胺的胞体或树突中很少见到。然而,在LC头极的树突中偶尔可观察到NMDA-R1的过氧化物酶标记。这些树突中的大多数缺乏可检测到的TH水平,尽管TH免疫反应性在神经毡中很明显。含有NMDA-R1-li免疫反应性的树突通常接受来自未标记终末的不对称(兴奋性类型)接触。NMDA-R1-li免疫反应性轴突终末通常含有小而清亮的囊泡以及大的致密核心囊泡,并且常常与未标记的树突、轴突终末和/或胶质细胞突起相邻。这些结果提供了首个超微结构证据,表明NMDA-R1-li免疫反应性选择性地分布在LC内的星形胶质细胞突起和突触前轴突终末内。